NYSE

Sherwin-Williams Company (The) (SHW)

636 Thanks from members

Sherwin-Williams (SHW) demonstrates strong pricing power and Q2 2026 earnings beats that prompted upward guidance revisions, though analysts remain cautious regarding premium valuations and potential H2 margin headwinds.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →